Government vendor · Mississauga, Ontario
GlaxoSmithKline Inc.
Contracts with the federal government, Jun 2004 to Apr 2026. Based in Mississauga, Ontario, going by its postal code.
- Federal contracts
- $78.3M
- 48 contracts
- Buyers
- 5
- departments and agencies
- Non-competitive
- 32%
- of 34 contracts that say how they were awarded
- First and latest
- 2004–2026
Federal contracts over $10,000, contracts dated Jan 2004 to Sep 2026, each counted once at its latest reported value. Source: Treasury Board proactive publication of contracts, published October 13, 2026.
An organization with this name is registered to lobby the federal government (matched by name). Which MPs it met, on MyMP
See this vendor’s records on the government’s contract search
Who it sells to
| Department or agency | Contracts | Total |
|---|---|---|
| Public Health Agency of Canada | 3 | $60.2M |
| National Defence | 6 | $13.4M |
| Correctional Service of Canada | 27 | $4.3M |
| Health Canada | 10 | $250K |
| Global Affairs Canada | 2 | $155K |
What it sells
By the Treasury Board object code each contract was filed under.
| Category | Contracts | Total |
|---|---|---|
| Research contracts | 1 | $53.1M |
| Pharmaceutical and Other Medicinal Products | 37 | $11.1M |
| Medical supplies, etc | 2 | $516K |
| Employee relocation outside Canada and/or return | 2 | $155K |
Largest contracts
| Date | Buyer | What | How awarded | Value |
|---|---|---|---|---|
| Dec 2009 | Public Health Agency of Canada | Research contracts | Non-competitive | $53,103,659 |
| May 2009 | National Defence | Drugs and Biologicals | — | $11,400,000 |
| Oct 2019 | Public Health Agency of Canada | Pharmaceutical and Other Medicinal Products | Competitive | $6,373,928 |
| Jan 2016 | Correctional Service of Canada | Pharmaceutical and Other Medicinal Products | Competitive: open bidding | $1,121,116 |
| May 2007 | National Defence | Drugs and Biologicals | — | $749,976 |
| Feb 2011 | National Defence | DRUGS AND BIOLOGICALS | — | $730,656 |
| Mar 2026 | Public Health Agency of Canada | Pharmaceutical and Other Medicinal Products | Non-competitive1 bid | $685,797 |
| Mar 2022 | Correctional Service of Canada | Pharmaceutical and Other Medicinal Products | Non-competitive1 bid | $495,040 |
| Mar 2013 | Correctional Service of Canada | Medical supplies, etc | — | $482,677 |
| Feb 2019 | Correctional Service of Canada | Pharmaceutical and Other Medicinal Products | Non-competitive | $406,292 |
By year
| Year | Contracts | Total |
|---|---|---|
| 2004 | 1 | $126K |
| 2007 | 1 | $750K |
| 2009 | 2 | $64.5M |
| 2010 | 4 | $551K |
| 2011 | 1 | $731K |
| 2012 | 1 | $13K |
| 2013 | 1 | $483K |
| 2014 | 4 | $160K |
| 2015 | 3 | $264K |
| 2016 | 2 | $1.4M |
| 2017 | 2 | $87K |
| 2018 | 8 | $352K |
| 2019 | 4 | $6.9M |
| 2020 | 4 | $225K |
| 2022 | 4 | $620K |
| 2023 | 2 | $67K |
| 2024 | 2 | $217K |
| 2026 | 2 | $824K |
Federal contracts
Newest first. Each at its latest reported value, amendments included.
CanadaBuys award notices
Contracts this vendor won through CanadaBuys since 2022.
| Awarded | Supplier | What | Buyer | Value |
|---|---|---|---|---|
| Apr 2026 | GlaxoSmithKline Inc. | Hepatitis B Vaccines GSK | Department of Public Works and Government Services (PSPC) | $9,462,827 |
| Mar 2026 | GlaxoSmithKline Inc. | Contract (GSK) - Supply Pertussis-containing vaccines | Department of National Defence (DND); Correctional Service of Canada (CSC); Department of Health (HC) | $29,400,277 |
| Feb 2026 | GlaxoSmithKline Inc. | Meningococcal B Vaccine 2026 - GSK | Department of Public Works and Government Services (PSPC) | $3,147,955 |
| Jun 2024 | GlaxoSmithKline Inc. | Amendment 003 Relenza | Department of Public Works and Government Services (PSPC) | $3,554,374 |
| Mar 2024 | GlaxoSmithKline Inc. | MMR, MMRV and Varicella vaccins | Department of Public Works and Government Services (PSPC) | $66,055,589 |
| Jan 2023 | GlaxoSmithKline Inc. | Amend 002 Meningococcal C and Quadrivalent Vaccines - GSK | Department of Public Works and Government Services (PSPC) | $8,292,896 |
| Jan 2023 | GlaxoSmithKline Inc. | Amend 006 - Meningococcal B Vaccine - GSK | Department of Public Works and Government Services (PSPC) | $8,379,451 |
CanadaBuys award notices since Aug 2022. They overlap the Treasury Board contract figures and are never added to them. Source: CanadaBuys open data, October 12, 2026.